Edwards Lifesciences Corporation Common Stock vs Hyperliquid Strategies Inc Common Stock — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.21 (market cap $48.56B), while Hyperliquid Strategies Inc Common Stock trades at $11.11 (market cap $2.24B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 21.7× Hyperliquid Strategies Inc Common Stock's market cap, and Hyperliquid Strategies Inc Common Stock is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | PURR | |
|---|---|---|
Market Cap | $48.56B | $2.24B |
Volume | 6,520,488 | 14,135,020 |
Sector | Health | Financials |
52-Week High | $95.18 | $14.09 |
52-Week Low | $72.65 | $3.10 |
Enterprise Value | $45.01B | $2.10B |
Typical Hold Time | — | 1 Days |
Trailing returns across standard periods
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →Hyperliquid Strategies is a digital asset treasury company focused on managing a treasury of HYPE tokens, the native digital assets of the Hyperliquid Layer-1 blockchain.
Read more on PURR →